Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Mirum Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 104 | 117 | +13 |
| Shares | 33.3M | 34.7M | +1.34M (+4.0%) |
| Value | $650.2M | $832.9M | +$182.6M (+28.1%) |
New holders (24)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (11)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 175,122 | $3.41M |
| Stonepine Capital Management, LLC | 108,769 | $2.12M |
| Octagon Capital Advisors LP | 100,000 | $1.95M |
| Jackson Creek Investment Advisors LLC | 33,540 | $654.0K |
| Jump Financial, LLC | 25,000 | $487.5K |
| Voloridge Investment Management, LLC | 24,989 | $487.3K |
| Panagora Asset Management Inc | 21,270 | $414.8K |
| Squarepoint Ops LLC | 15,117 | $294.8K |
| Simplex Trading, LLC | 3,098 | $60.0K |
| Sandia Investment Management LP | 2,200 | $42.9K |
| The PNC Financial Services Group, Inc. | 18 | $351 |